US Pharma MarketingSondermind and Limbic are evaluating digital health devices intended to help with anxiety and depression.
FDA adds two behavioral health firms to TEMPO pilot
FDA adds two behavioral health firms to TEMPO pilot is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: MedTech Dive